サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1599902

アジア太平洋の非侵襲的出生前検査（NIPT）市場：検査法別、プラットフォーム別、エンドユーザー別、用途別、国別 - 分析と予測（2023年～2033年）

Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market: Focus on Method, Platform, End User, Application, and Country - Analysis and Forecast, 2023-2033

出版日
発行
BIS Research
ページ情報
英文 68 Pages
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アジア太平洋の非侵襲的出生前検査（NIPT）市場：検査法別、プラットフォーム別、エンドユーザー別、用途別、国別 - 分析と予測（2023年～2033年）
出版日: 2024年11月29日
発行: BIS Research
ページ情報: 英文 68 Pages
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の非侵襲的出生前検査（NIPT）の市場規模は、2023年に6億5,920万米ドルとなりました。

同市場は、予測期間の2023年～2033年に15.43%のCAGRで拡大し、2033年には27億6,730万米ドルに達すると予測されています。支持的なヘルスケア政策の採用、スクリーニング検査の保険適用範囲の拡大、継続的な技術進歩、地域全体での商機拡大、妊産婦や医療提供者の間での非侵襲的検査方法への嗜好の高まりが、アジア太平洋の非侵襲的出生前検査（NIPT）市場を推進する主な要因です。

主要市場統計
予測期間 2023年～2033年
2023年の評価 6億5,920万米ドル
2033年の予測 27億6,730万米ドル
CAGR 15.43%

アジア太平洋の非侵襲的出生前検査（NIPT）市場は、同地域におけるヘルスケア支出の増加と、洗練された出生前スクリーニング技術に関する知識の高まりにより、大きく拡大しています。NIPTは、その正確性、安全性、非侵襲性の高さから、母体の血液から細胞を含まない胎児のDNAを調べる画期的な技術として、ますます人気が高まっています。妊娠中、パタウ症候群、エドワーズ症候群、ダウン症候群などの染色体異常を同定するために頻繁に使用されます。

母体の高齢化、高度な遺伝子技術の利用、正確でタイムリーな出生前診断の必要性が、市場の成長を促進しています。NIPTの採用は、多くのアジア太平洋諸国における出生前診断の保険適用拡大とヘルスケア改革の実施によってさらに後押しされています。

市場の主要企業は、この地域の多様な人口と幅広い所得水準に対応するため、手頃な価格の検査ソリューションの開発に注力しています。国際企業と地域のヘルスケアプロバイダーとのパートナーシップは、特に発展途上国において、認知度とアクセシビリティを高めています。

当レポートでは、アジア太平洋の非侵襲的出生前検査（NIPT）市場について調査し、市場の概要とともに、検査法別、プラットフォーム別、エンドユーザー別、用途別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

  • 動向：現在および将来の影響評価
  • サプライチェーンの概要
  • 研究開発レビュー
  • 規制状況
  • 償還シナリオ
  • 市場力学の概要

第2章 地域

  • 促進要因と抑制要因
  • 地域別概要
  • アジア太平洋

第3章 市場-競合ベンチマーキングと企業プロファイル

  • 競合情勢
    • BGI Genomics
    • Annoroad Gene Technology

第4章 調査手法

図表

List of Figures

  • Figure 1: Asia-pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022, 2026, and 2033
  • Figure 2: Asia-pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022, 2026, and 2033
  • Figure 3: Asia-pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022, 2026, and 2033
  • Figure 4: Asia-pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022, 2026, and 2033
  • Figure 5: Non-Invasive Prenatal Testing Market, Recent Developments, 2023
  • Figure 6: Supply Chain of NIPT Market
  • Figure 7: NIPT Market, Patent Analysis, (by Country), January 2020-December 2023
  • Figure 8: NIPT Market, Patent Analysis, (by Year), January 2020-December 2023
  • Figure 9: Reimbursement Scenario in Major Countries of the NIPT Market
  • Figure 10: Impact Analysis of Market Navigating Factors, 2022-2033
  • Figure 11: Age of Mother at Childbirth over the Years
  • Figure 12: Reimbursement Scenario in Major Countries
  • Figure 13: Number of Tests Processed by Natera, Inc., 2018-2020
  • Figure 14: Positives from Data of 75,000 NIPT Tests Showing False Positives
  • Figure 15: Recent Developments in APAC by Key Companies
  • Figure 16: Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
  • Figure 17: Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2023-2033
  • Figure 18: China Non-Invasive Prenatal Testing Market, Thousand, 2023-2033
  • Figure 19: China Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 20: India Non-Invasive Prenatal Testing Market, Thousand Units, 2023-2033
  • Figure 21: India Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 22: Japan Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
  • Figure 23: Japan Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, Thousand Units, 2022-2033
  • Figure 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market, $Million, 2022-2033
  • Figure 26: Share of Strategic Initiatives
  • Figure 27: Data Triangulation
  • Figure 28: Top-Down and Bottom-Up
  • Figure 29: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Non-Invasive Prenatal Testing Market, Opportunities
  • Table 3: Key Companies' Partnerships and Alliances
  • Table 4: NIPT Tests in the NIPT Market and their Corresponding Applications
  • Table 5: Risk of Chromosomal Abnormality w.r.t Maternal Age
  • Table 6: Non-Invasive Prenatal Testing Market (by Region), Thousands Units, 2022-2033
  • Table 7: Non-Invasive Prenatal Testing Market (by Region), $Million, 2022-2033
  • Table 8: Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 9: Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 10: Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 11: Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 12: China Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 13: China Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 14: China Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 15: China Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 16: India Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 17: India Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 18: India Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 19: India Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 20: Japan Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 21: Japan Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 22: Japan Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 23: Japan Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 24: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Application), $Million, 2022-2033
  • Table 25: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by End User), $Million, 2022-2033
  • Table 26: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Platform), $Million, 2022-2033
  • Table 27: Rest-of-Asia-Pacific Non-Invasive Prenatal Testing Market (by Method), $Million, 2022-2033
  • Table 28: Market Share (2022)
目次
Product Code: BHL2407SS

Introduction to Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market

The Asia-Pacific NIPT market was valued at $659.2 million in 2023 and is expected to reach $2,767.3 million by 2033, registering a CAGR of 15.43% during the forecast period 2023-2033. The adoption of supportive healthcare policies, the growing inclusion of screening procedures in insurance coverage, ongoing technological advancements, the expansion of commercial opportunities throughout the region, and the growing preference for non-invasive testing methods among expectant parents and healthcare providers are the main factors propelling the APAC NIPT market.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$659.2 Million
2033 Forecast$2,767.3 Million
CAGR15.43%

The market for non-invasive prenatal testing (NIPT) in Asia-Pacific is expanding significantly due to increased healthcare spending in the region and growing knowledge of sophisticated prenatal screening techniques. Because of its great accuracy, safety, and non-invasiveness, NIPT-a ground-breaking technology that examines cell-free fetal DNA from maternal blood-is becoming more and more popular. During pregnancy, it is frequently used to identify chromosomal abnormalities such Patau syndrome, Edwards syndrome, and Down syndrome.

Growing maternal age, the use of sophisticated genetic technologies, and the need for accurate and timely prenatal diagnostics are driving the market's growth. The adoption of NIPT is being further supported by the expansion of insurance coverage for prenatal care and the implementation of healthcare reforms in many Asia-Pacific nations.

The market's major players are concentrating on creating affordable testing solutions to serve the region's diverse population and range of income levels. Partnerships between international corporations and regional healthcare providers are increasing awareness and accessibility, especially in developing nations.

As prenatal health awareness rises and healthcare infrastructure improves, the APAC NIPT market is expected to grow rapidly. It will be crucial in improving maternal and fetal health outcomes throughout the area.

Market Segmentation:

Segmentation 1: by Application

  • Trisomy Detection
  • Microdeletion Detection
  • Sex Chromosome Aneuploidy Detection
  • Others

Segmentation 2: by End User

  • Hospitals
  • Diagnostic Laboratories
  • Others

Segmentation 3: by Platform

  • NGS
  • PCR
  • Others

Segmentation 4: by Method

  • cfDNA
  • FCMB

Segmentation 5: by Country

  • China
  • India
  • Japan
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific NIPT market (by application) has been segmented into detailed segments of the application of NIPT based on applications, including trisomy detection, microdeletion detection, sex chromosome aneuploidy detection, and others.

Growth/Marketing Strategy: Constant advancement and innovation to enhance performance and efficiency can enabled prominent players to command premium prices while maintaining growth in revenue and volume.

Competitive Strategy: Key players in the Asia-Pacific NIPT market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific NIPT market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • BGI Genomics
  • Annoroad Gene Technology

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Increasing Strategic Partnerships and Alliances between Market Players
    • 1.1.2 Expanding Applications in NIPT Products
  • 1.2 Supply Chain Overview
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
    • 1.4.1 Regulatory Scenario in China
    • 1.4.2 Regulatory Scenario in India
    • 1.4.3 Regulatory Scenario in Australia
    • 1.4.4 Regulatory Scenario in Japan
  • 1.5 Reimbursement Scenario
  • 1.6 Market Dynamics Overview
    • 1.6.1 Market Drivers
      • 1.6.1.1 High Incidence of Genetic Disorders
      • 1.6.1.2 Rising Maternal Age
      • 1.6.1.3 Increasing Number of Reimbursement Policies toward Genetic Coverage
      • 1.6.1.4 Increased Emphasis on Early Detection and Prevention
    • 1.6.2 Market Restraints
      • 1.6.2.1 Stringent Regulatory Guidelines and Ethical Hurdles
      • 1.6.2.2 Lack of Awareness Regarding NIPT
      • 1.6.2.3 Limitations and Considerations in Non-Invasive Prenatal Testing
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Leveraging the Opportunities Arising from the Growing Markets in Asia
      • 1.6.3.2 Increasing Focus on Non-Invasive Pre-Implantation Genetic Testing (niPGT)

2 Regions

  • 2.1 Drivers and Restraints
  • 2.2 Regional Summary
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 China
    • 2.3.7 India
    • 2.3.8 Japan
    • 2.3.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
    • 3.1.1 BGI Genomics
      • 3.1.1.1 Overview
      • 3.1.1.2 Product Portfolio
      • 3.1.1.3 Top Competitors
      • 3.1.1.4 Target Customers
      • 3.1.1.5 Key Personnel
      • 3.1.1.6 Analyst View
    • 3.1.2 Annoroad Gene Technology
      • 3.1.2.1 Overview
      • 3.1.2.2 Product Portfolio
      • 3.1.2.3 Top Competitors
      • 3.1.2.4 Target Customers
      • 3.1.2.5 Key Personnel
      • 3.1.2.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast